š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a Phase 2, randomized, double-masked, placebo-controlled, parallel-...
Status
Completed
Location
Meir Hospital
Start Date
2007-01
Trial ID
NCT00349466
This study will test the hypothesis that CF101, which is under development ...
Status
Completed
Location
Haemek Medical Center
Start Date
2007-06
Trial ID
NCT00428974
This study will test the hypothesis that CF101, administered orally, will r...
Status
Completed
Location
Specialized Hospital for Active Treatment for Eye Diseases "Zrenie"
Start Date
2010-10
Trial ID
NCT01033422
Treatments Being Tested
This is a Phase 2, randomized, double-masked, placebo-controlled study subj...
Status
Withdrawn
Location
Bnei-Zion Medical Center
Start Date
2019-01
Trial ID
NCT01905124
This trial will test the hypothesis that the administration of CF101, a nov...
Status
Terminated
Location
Can-Fite Investigational Site #252
Start Date
2017-10-30
Trial ID
NCT02647762
Treatments Being Tested
Patients with documented moderate COVID-19 infection will be randomized 1:1...
Status
Completed
Location
II Multiprofile Hospital for Active Treatment - Sofia EAD
Start Date
2021-01-06
Trial ID
NCT04333472
Treatments Being Tested
This study will test the effectiveness of CF101 in treating the symptoms of...
Status
Withdrawn
Location
Barzilai Medical Center
Start Date
2018-11
Trial ID
NCT00837291
Eligible patients with Psoriasis will be treated with CF101 or placebo twic...
Status
Completed
Location
Mount Sinai School of Medicine
Start Date
2011-07
Trial ID
NCT01265667
The primary objective of this trial is to: 1\. Evaluate the efficacy of pi...
Status
Not Yet Recruiting
Location
IRCCS Ospedale Pediatrico Bambino GesĆ¹
Start Date
2026-06-01
Trial ID
NCT07410455
Treatments Being Tested
This trial will test the hypothesis that the addition of CF101, a novel ant...
Status
Completed
Location
Clinic of Rheumatology at MHAT 'Sveti Georgi'
Start Date
2008-02
Trial ID
NCT00556894